HRT :: Reducing cardiovascular disease risk factors when discontinuing hormone replacement therapy

Hormone replacement therapy (HRT) has been shown to reduce many cardiovascular disease (CVD) risk factors, but many women have stopped using HRT due to reports from the Women?s Health Initiative that HRT may increase the risk of breast cancer and heart disease.

Breast Cancer :: Decreased breast cancer rates reflect HRT reduction & saturation of mammography

A new study, published in the Online Open Access journal Breast Cancer Research, reveals two distinct patterns in the recent breast cancer rates in U.S. women: a downturn in the incidence rates in almost all age groups above 45 years beginning in 1998/1999, consistent with a levelling off of mammography utilization, and a sharp fall in the rates between 2002 and 2003 in the age groups 50-69 years, likely reflecting the early benefit of the reduced use of HRT.

Breast Cancer :: Decrease in breast cancer rates related to reduction in use of hormone replacement therapy

The sharp decline in the rate of new breast cancer cases in 2003 may be related to a national decline in the use of hormone replacement therapy (HRT), according to a new report in the April 19, 2007, issue of the New England Journal of Medicine.

Breast Cancer :: Breast cancer incidence continues to trend low in 2004, decline supports role of HRT

An extended analysis of cancer rates reinforces a strong association between use of hormone replacement therapy and increased breast cancer incidence, according to research led by scientists at the University of Texas M. D. Anderson Cancer Center and published in the April 19 issue of the New England Journal of Medicine.